CLINICAL_TRIALS
trial_result
· 2014-10-13
Clinical Trial Update: Efficacy and Safety Study of MP-435 in Combination With Methotrexate (MTX) in Patients With Rheumatoid Arthritis [Phase 2]
Summary
A Phase 2 trial evaluating MP-435 in combination with methotrexate for rheumatoid arthritis has completed, with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tanabe Pharma Corporation | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2014-10-13